Corbeau, I.; Thezenas, S.; Maran-Gonzalez, A.; Colombo, P.-E.; Jacot, W.; Guiu, S.
Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers 2020, 12, 2666.
https://doi.org/10.3390/cancers12092666
AMA Style
Corbeau I, Thezenas S, Maran-Gonzalez A, Colombo P-E, Jacot W, Guiu S.
Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers. 2020; 12(9):2666.
https://doi.org/10.3390/cancers12092666
Chicago/Turabian Style
Corbeau, Ileana, Simon Thezenas, Aurelie Maran-Gonzalez, Pierre-Emmanuel Colombo, William Jacot, and Severine Guiu.
2020. "Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy" Cancers 12, no. 9: 2666.
https://doi.org/10.3390/cancers12092666
APA Style
Corbeau, I., Thezenas, S., Maran-Gonzalez, A., Colombo, P.-E., Jacot, W., & Guiu, S.
(2020). Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers, 12(9), 2666.
https://doi.org/10.3390/cancers12092666